CAS No. |
2832865-25-3 |
中文名称 |
ERD-3111(化学结构未公开/非IUPAC系统命名;需提供完整IUPAC名称或结构式后方可生成符合CCS规则的系统中文名) |
英文名称 |
ERD-3111 |
别名 |
ERD-3111;3-{6-[2-(9-{4-[(6S,8R)-7-(2,2-difluoroethyl)-8-methyl-3H,6H,7H,8H,9H-pyrido[4,3-e]indazol-6-yl]-3,5-difluorophenyl}-3,9-diazaspiro[5.5]undecan-3-yl)-2-oxoethyl]-1,3-dioxo-1H,2H,3H,5H,6H,7H-pyrrolo[3,4-f]isoindol-2-yl}piperidine-2,6-dione;6-(2-(9-(4-((6S,8R)-7-(2,2-difluoroethyl)-8-methyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)-3,5-difluorophenyl)-3,9-diazaspiro[5.5]undecan-3-yl)-2-oxoethyl)-2-(2,6-dioxopiperidin-3-yl)-6 |
标准英文名 |
6-(2-(9-(4-((6S,8R)-7-(2,2-difluoroethyl)-8-methyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)-3,5-difluorophenyl)-3,9-diazaspiro[5.5]undecan-3-yl)-2-oxoethyl)-2-(2,6-dioxopiperidin-3-yl)-6,7-dihydropyrrolo[3,4-f]isoindole-1,3(2H,5H)-dione |
分子式 |
C45H46F4N8O5 |
分子量 |
854.91
|
精确分子量 |
854.35
|
SMILES |
O=C1N(C(CC2)C(NC2=O)=O)C(C3=C1C=C4C(CN(CC(N5CCC6(CCN(C7=CC(F)=C([C@H]8N(CC(F)F)[C@H](C)CC9=C8C=CC%10=C9C=NN%10)C(F)=C7)CC6)CC5)=O)C4)=C3)=O |
标准SMILES |
C[C@@H]1CC2=C(C=CC3NN=CC2=3)[C@@H](C2=C(F)C=C(C=C2F)N2CCC3(CCN(CC3)C(=O)CN3CC4=CC5=C(C=C4C3)C(=O)N(C3CCC(=O)NC3=O)C5=O)CC2)N1CC(F)F |
用途 |
ERD-3111 is a potent, orally active PROTAC ERα degrader (DC50: 0.5 nM) that inhibits tumor growth in parental MCF-7 xenograft models with wild-type ER and in two clinically relevant ESR1-mutant mouse models; it is useful for the research of ER+ breast cancer. |
InChIKey |
RASJDLFEGKXLIV-LQFKIQTBSA-N |